RT Journal Article
SR Electronic
T1 Depression and anxiety before and during the COVID-19 lockdown: a longitudinal cohort study with university students
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.23.21252284
DO 10.1101/2021.02.23.21252284
A1 da Conceição, Virgínia
A1 Rothes, Inês
A1 Gusmão, Ricardo
A1 Barros, Henrique
YR 2021
UL http://medrxiv.org/content/early/2021/02/24/2021.02.23.21252284.abstract
AB Background For young people, just as in the general population, COVID-19 caused many changes in their lives, including an increased risk for mental illness symptoms. We aimed to study the impact of the COVID-19 pandemic in anxiety and depression symptoms in a cohort of university students.Methods This study is part of broader longitudinal research on university students’ mental health with data of the Portuguese version of The Patient Health Questionnaire (PHQ-9) and the Portuguese version of the Generalised Anxiety Disorder (GAD-7) with evaluations on January, May and October 2019 and June 2020, as well as socio-demographic information.Results 341 university students (257 females and 84 males) were included, with a mean age of 19.91 (SD=1.58). In June 2020, the mean for perceived wellbeing loss was 60.47% (SD=26.56) and 59.54% (SD=28.95) for mental health loss. The proportion of students with scores equal to or above 15 in the PHQ-9 ranged between 22.6% and 25.5% in 2019 and 37.0% in June 2020. The proportion of GAD-7 scores above cut-off ten ranged between 46.0% and 47.8% in 2019 and 64.5% in 2020. Compared with preceding trends, PHQ-9 scores were 3.11 (CI=2.40-3.83) higher than expected, and GAD-7 scores were 3.56 (CI=2.75-5.37) higher.Discussion COVID-19 impacted negatively depressive and anxiety symptoms, confirming previous studies and young people’s vulnerability in such uncertain times.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialISRCTN63459073Funding StatementThrough FCT - Foundation for Science and Technology, I.P., national funds finance this work under the project UIDB / 04750/2020. The sponsor had no role in the study design, in the data collection, interpretation of data, writing of the report, nor in the the decision to submit the paper for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:It complies with the relevant national and institutional committees' ethical standards on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. The Institute of Public Health of the University of Porto ethics committee approved the research with the I.D. reference CE18096. All participants signed an informed consent digital form according to the Helsinki and Oviedo Conventions.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available upon request